135 related articles for article (PubMed ID: 6379201)
1. Production and characterization of monoclonal antibodies to the myelin glycolipid sulfatide.
Hofstetter W; Bologa L; Wetterwald A; Z'graggen A; Blaser K; Herschkowitz N
J Neurosci Res; 1984; 11(4):341-50. PubMed ID: 6379201
[TBL] [Abstract][Full Text] [Related]
2. Galactocerebroside and sulfatide independently mediate Ca2+ responses in oligodendrocytes.
Dyer CA; Benjamins JA
J Neurosci Res; 1991 Dec; 30(4):699-711. PubMed ID: 1787543
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical studies of lipids. IV. Reactions of anti-sulfatide antibodies with sulfatide in liposomal and myelin membranes.
Uemura K; Yuzawa-Watanabe M; Kitazawa N; Taketomi T
J Biochem; 1980 Apr; 87(4):1221-7. PubMed ID: 7190144
[TBL] [Abstract][Full Text] [Related]
4. Expression of the myelin and oligodendrocyte progenitor marker sulfatide in neurons and astrocytes of adult rat brain.
Pernber Z; Molander-Melin M; Berthold CH; Hansson E; Fredman P
J Neurosci Res; 2002 Jul; 69(1):86-93. PubMed ID: 12111819
[TBL] [Abstract][Full Text] [Related]
5. A new oligodendrocyte specific plasma membrane surface protein identified by a monoclonal antibody produced in vitro.
Birling MC; Nussbaum F; Nussbaum JL
J Neurosci Res; 1994 Aug; 38(5):538-50. PubMed ID: 7815472
[TBL] [Abstract][Full Text] [Related]
6. Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice.
Hirahara Y; Bansal R; Honke K; Ikenaka K; Wada Y
Glia; 2004 Feb; 45(3):269-77. PubMed ID: 14730700
[TBL] [Abstract][Full Text] [Related]
7. Myelin-specific domain on the plasmalemma of oligodendroglia: differential expression in the rat and hypomyelinating mouse mutants jimpy and quaking.
Gard AL; Dutton GR
J Neurosci Res; 1987; 17(4):329-43. PubMed ID: 2442404
[TBL] [Abstract][Full Text] [Related]
8. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development.
Bansal R; Warrington AE; Gard AL; Ranscht B; Pfeiffer SE
J Neurosci Res; 1989 Dec; 24(4):548-57. PubMed ID: 2600978
[TBL] [Abstract][Full Text] [Related]
9. Dysmyelination induced in vitro by IgM antisulfatide and antigalactocerebroside monoclonal antibodies.
Rosenbluth J; Moon D
J Neurosci Res; 2003 Jan; 71(1):104-9. PubMed ID: 12478618
[TBL] [Abstract][Full Text] [Related]
10. Patterns of reactivity with anti-glycolipid antibodies in human primary brain tumors.
Li J; Pearl DK; Pfeiffer SE; Yates AJ
J Neurosci Res; 1994 Oct; 39(2):148-58. PubMed ID: 7530777
[TBL] [Abstract][Full Text] [Related]
11. Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?
Podbielska M; Hogan EL
Mult Scler; 2009 Sep; 15(9):1011-29. PubMed ID: 19692432
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to distinct regions of human myelin proteolipid protein simultaneously recognize central nervous system myelin and neurons of many vertebrate species.
Greenfield EA; Reddy J; Lees A; Dyer CA; Koul O; Nguyen K; Bell S; Kassam N; Hinojoza J; Eaton MJ; Lees MB; Kuchroo VK; Sobel RA
J Neurosci Res; 2006 Feb; 83(3):415-31. PubMed ID: 16416423
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of mouse antibodies against the brain lipid sulfatide.
Hofstetter W; Heusser CH; Herschkowitz N; Blaser K
J Immunol Methods; 1983 Feb; 57(1-3):99-109. PubMed ID: 6827115
[TBL] [Abstract][Full Text] [Related]
14. Myelin palingenesis. 2. Immunocytochemical localization of myelin/oligodendrocyte glycolipids in multilamellar structures.
Arvanitis D; Dumas M; Szuchet S
Dev Neurosci; 1992; 14(5-6):328-35. PubMed ID: 1306158
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of oligodendrocytes cultured from developing rat brain is enhanced by exogenous GM3 ganglioside.
Yim SH; Farrer RG; Hammer JA; Yavin E; Quarles RH
J Neurosci Res; 1994 Jun; 38(3):268-81. PubMed ID: 7523687
[TBL] [Abstract][Full Text] [Related]
16. Sulfatide binding properties of murine and human antiganglioside antibodies.
Townson K; Greenshields KN; Veitch J; Nicholl D; Eckhardt M; Galanina O; Bovin N; Samain E; Antoine T; Bundle D; Zhang P; Ling CC; Willison HJ
Glycobiology; 2007 Nov; 17(11):1156-66. PubMed ID: 17855742
[TBL] [Abstract][Full Text] [Related]
17. Novel molecular insights into the critical role of sulfatide in myelin maintenance/function.
Palavicini JP; Wang C; Chen L; Ahmar S; Higuera JD; Dupree JL; Han X
J Neurochem; 2016 Oct; 139(1):40-54. PubMed ID: 27417284
[TBL] [Abstract][Full Text] [Related]
18. Identification and functional characterization of mouse TPO1 as a myelin membrane protein.
Fukazawa N; Ayukawa K; Nishikawa K; Ohashi H; Ichihara N; Hikawa Y; Abe T; Kudo Y; Kiyama H; Wada K; Aoki S
Brain Res; 2006 Jan; 1070(1):1-14. PubMed ID: 16405874
[TBL] [Abstract][Full Text] [Related]
19. Production of a recombinant single-chain variable-fragment (scFv) antibody against sulfoglycolipid.
Cheng X; Zhang Y; Kotani N; Watanabe T; Lee S; Wang X; Kawashima I; Tai T; Taniguchi N; Honke K
J Biochem; 2005 Mar; 137(3):415-21. PubMed ID: 15809345
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of the binding epitope of a novel monoclonal antibody to sulfatide (sulfogalactosylceramide) OL-2: applications of antigen immunodetections in brain tissues and urinary samples.
Colsch B; Baumann N; Ghandour MS
J Neuroimmunol; 2008 Jan; 193(1-2):52-8. PubMed ID: 18023883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
